Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
MRVI1 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | Q9Y6F6 |
|---|---|
| Clone Names | 100324190 |
| Gene ID | 10335 |
|---|---|
| Other Names | Protein MRVI1, Inositol 1, 5-trisphosphate receptor-associated cGMP kinase substrate, JAW1-related protein MRVI1, MRVI1, IRAG, JAW1L |
| Target/Specificity | The synthetic peptide sequence used to generate the antibody AP13441a was selected from the N-term region of MRVI1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | IRAG1 (HGNC:7237) |
|---|---|
| Synonyms | IRAG, JAW1L, MRVI1 |
| Function | Plays a role as NO/PRKG1-dependent regulator of IP3-induced calcium release; its phosphorylation by PRKG1 inhibits bradykinin and IP3-induced calcium release from intracellular stores. Recruits PRKG1 to the endoplasmic reticulum and may mediate the assembly of PRKG1 and ITPR1 in a macrocomplex. Involved in PRKG1 signaling cascade leading to inhibition of platelet activation and aggregation. Mediates also NO- dependent inhibition of calcium signaling in gastrointestinal smooth muscle contributing to NO-dependent relaxation. |
| Cellular Location | Cytoplasm, perinuclear region. Sarcoplasmic reticulum. Membrane; Single-pass membrane protein |
| Tissue Location | Expressed in the colon, rectum, and cultured colonic smooth muscle. Detected in various cancer cell lines |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene is similar to a putative mouse tumor suppressorgene (Mrvi1) that is frequently disrupted by mouse AIDS-relatedvirus (MRV). The encoded protein, which is found in the membrane ofthe endoplasmic reticulum, is similar to Jaw1, alymphoid-restricted protein whose expression is downregulatedduring lymphoid differentiation. Studies in mouse suggest that MRVintegration at Mrvi1 induces myeloid leukemia by altering theexpression of a gene important for myeloid cell growth and/ordifferentiation, and thus this gene may function as a myeloidleukemia tumor suppressor gene. Several alternatively splicedtranscript variants encoding different isoforms have been found forthis gene, few of which initiate translation at a non-AUG (CUG)start site.
References
Johnson, A.D., et al. Nat. Genet. 42(7):608-613(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Xu, J., et al. Proc. Natl. Acad. Sci. U.S.A. 107(5):2136-2140(2010)Antl, M., et al. Blood 109(2):552-559(2007)Casteel, D.E., et al. J. Biol. Chem. 280(46):38211-38218(2005)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
